MD Anderson becomes Hengrui's latest academic partner<span class="*Red-type+bold">

Jiangsu Hengrui Medicine Co. Ltd. (Shanghai:600276) and the University of Texas MD Anderson Cancer Center began a three-year translational research collaboration to develop combination immunotherapies for cancer.

Last week, Hengrui and Albert Einstein College of Medicine partnered to discover new oncology targets and develop therapies. ...